| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |